user

Functional proteomic aberrations post-chemotherapy with paclitaxel and carboplatin in patients with advanced ovarian cancer

被引：0
|
作者：
Lee, Sanghoon [1 ]
Zhao, Li [1 ]
Celestino, Joseph [1 ]
Rangel, Kelly M. [1 ]
Hajek, Richard A. [1 ]
Kim, Mark S. [1 ]
Sharafi, Sara E. [1 ]
Liu, Jinsong [1 ]
Fleming, Nicole D. [1 ]
Lu, Karen H. [1 ]
Zhang, Jianhua [1 ]
Futreal, P. Andrew [1 ]
Mills, Gordon B. [2 ]
Westin, Shannon N. [1 ]
Sood, Anil K. [1 ]
Jazaeri, Amir A. [1 ]
Coleman, Robert L. [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-2941
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2941
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Paclitaxel/carboplatin for the initial treatment of advanced ovarian cancer
    Neijt, JP
    du Bois, A
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 78 - 83
  • [22] Pharmacokinetic and pharmacodynamic analysis of combined chemotherapy with carboplatin and paclitaxel for patients with ovarian cancer
    Arakawa A.
    Nishikawa H.
    Suzumori K.
    Kato N.
    International Journal of Clinical Oncology, 2001, 6 (5) : 248 - 252
  • [23] The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer
    Dermitzakis, Emmanouil V.
    Kimiskidis, Vasilios K.
    Lazaridis, George
    Alexopoulou, Zoi
    Timotheadou, Eleni
    Papanikolaou, Alexandros
    Romanidou, Ourania
    Georgiadis, George
    Kalogeras, Konstantine T.
    Tsiptsios, Iakovos
    Tarlatzis, Basil
    Fountzilas, George
    BMC NEUROLOGY, 2016, 16
  • [24] The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer
    Emmanouil V. Dermitzakis
    Vasilios K. Kimiskidis
    George Lazaridis
    Zoi Alexopoulou
    Eleni Timotheadou
    Alexandros Papanikolaou
    Ourania Romanidou
    George Georgiadis
    Konstantine T. Kalogeras
    Iakovos Tsiptsios
    Basil Tarlatzis
    George Fountzilas
    BMC Neurology, 16
  • [25] Combination Chemotherapy with Carboplatin and Paclitaxel for Advanced Thymic Cancer
    Furugen, Makoto
    Sekine, Ikuo
    Tsuta, Koji
    Horinouchi, Hidehito
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Kubota, Kaoru
    Tamura, Tomohide
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (08) : 1013 - 1016
  • [26] Carboplatin and paclitaxel in patients with advanced ovarian cancer: A dose-finding study
    Huinink, WT
    Veenhof, C
    Huizing, M
    Rodenhuis, S
    Helmerhorst, T
    Dubbelman, R
    Dalesio, O
    Beijnen, J
    Winograd, B
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S31 - S33
  • [27] A phase II study of alternating paclitaxel and carboplatin in patients with advanced ovarian cancer
    Adams, M
    Mort, D
    Coleman, R
    Wiliams, L
    Evans, A
    Thompson, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 496 - 496
  • [28] Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer
    duBois, A
    Luck, HJ
    Meier, W
    Mobus, V
    Costa, S
    Richter, B
    Bauknecht, T
    Warm, M
    Schroeder, W
    Olbricht, S
    Nitz, U
    Jackisch, C
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 28 - 33
  • [29] Surgical cytoreduction and dose intensity of adjuvant paclitaxel and carboplatin chemotherapy in advanced epithelial ovarian cancer
    Shafer, A.
    Rubatt, J. M.
    Ayeni, T.
    Deal, A. M.
    Secord, A. A.
    Soper, J. T.
    Havrilesky, L. J.
    Van Le, L.
    Gehring, P. A.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S55 - S56
  • [30] Pharmacokinetics of combination chemotherapy with paclitaxel and carboplatin in a patient with advanced epithelial ovarian cancer undergoing hemodialysis
    Kodama, Junichi
    Sasaki, Aiko
    Masahiro, Satoko
    Seki, Noriko
    Kusumoto, Tomoyuki
    Nakamura, Keiichiro
    Hongo, Atsushi
    Hiramatsu, Yuji
    ONCOLOGY LETTERS, 2010, 1 (03) : 511 - 513
12345